Wealthcare Advisory Partners’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$246K Sell
3,514
-209
-6% -$14.6K 0.01% 862
2025
Q1
$274K Buy
3,723
+424
+13% +$31.2K 0.01% 771
2024
Q4
$216K Sell
3,299
-2,361
-42% -$155K 0.01% 833
2024
Q3
$441K Sell
5,660
-198
-3% -$15.4K 0.01% 596
2024
Q2
$457K Sell
5,858
-278
-5% -$21.7K 0.01% 557
2024
Q1
$416K Buy
6,136
+543
+10% +$36.8K 0.01% 573
2023
Q4
$377K Sell
5,593
-1,247
-18% -$84K 0.02% 546
2023
Q3
$463K Sell
6,840
-220
-3% -$14.9K 0.02% 450
2023
Q2
$505K Sell
7,060
-312
-4% -$22.3K 0.02% 446
2023
Q1
$512K Sell
7,372
-375
-5% -$26K 0.02% 454
2022
Q4
$525K Buy
7,747
+276
+4% +$18.7K 0.03% 411
2022
Q3
$410K Buy
7,471
+919
+14% +$50.4K 0.02% 411
2022
Q2
$433K Sell
6,552
-258
-4% -$17.1K 0.03% 354
2022
Q1
$452K Sell
6,810
-437
-6% -$29K 0.03% 328
2021
Q4
$422K Buy
7,247
+571
+9% +$33.3K 0.03% 349
2021
Q3
$401K Buy
6,676
+1,740
+35% +$105K 0.03% 357
2021
Q2
$296K Sell
4,936
-365
-7% -$21.9K 0.02% 431
2021
Q1
$264K Buy
5,301
+771
+17% +$38.4K 0.02% 421
2020
Q4
$226K Sell
4,530
-290
-6% -$14.5K 0.02% 374
2020
Q3
$264K Buy
4,820
+567
+13% +$31.1K 0.03% 290
2020
Q2
$225K Buy
4,253
+300
+8% +$15.9K 0.03% 278
2020
Q1
$177K Buy
3,953
+335
+9% +$15K 0.03% 275
2019
Q4
$180K Hold
3,618
0.02% 314
2019
Q3
$161K Buy
3,618
+299
+9% +$13.3K 0.02% 311
2019
Q2
$137K Hold
3,319
0.02% 325
2019
Q1
$134K Sell
3,319
-786
-19% -$31.7K 0.02% 290
2018
Q4
$156K Sell
4,105
-677
-14% -$25.7K 0.03% 244
2018
Q3
$189K Hold
4,782
0.03% 230
2018
Q2
$168K Buy
4,782
+300
+7% +$10.5K 0.03% 241
2018
Q1
$157K Sell
4,482
-1,125
-20% -$39.4K 0.04% 223
2017
Q4
$195K Buy
5,607
+182
+3% +$6.33K 0.05% 184
2017
Q3
$184K Buy
+5,425
New +$184K 0.05% 155